Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Personalized Cancer Vaccine”

123 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 123 results

Testing effectiveness (Phase 2)Study completedNCT06614140
What this trial is testing

Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors

Who this might be right for
CancerSolid Tumor, Adult
Seqker Biosciences, Inc. 8
Early research (Phase 1)Ended earlyNCT03121677
What this trial is testing

Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Washington University School of Medicine 4
Not applicableUnknownNCT05192460
What this trial is testing

Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver Cancer

Who this might be right for
Gastric CancerEsophageal CancerLiver Cancer
jianming xu 30
Not applicableUnknownNCT05359354
What this trial is testing

Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors

Who this might be right for
Solid Tumor
YueJuan Cheng 36
Not applicableUnknownNCT04145232
What this trial is testing

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

Who this might be right for
Non Small Cell Lung CancerNeoepitopesNeoantigens+3 more
Ardigen 30
Very early researchNot Yet RecruitingNCT06932861
What this trial is testing

Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma

Who this might be right for
Rhabdomyosarcoma
Xinxin Zhang 5
Early research (Phase 1)WithdrawnNCT03166254
What this trial is testing

Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNSCLCNon-small Cell Lung Cancer+1 more
Washington University School of Medicine
Very early researchEnrolling By InvitationNCT07316361
What this trial is testing

GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer

Who this might be right for
Endometrial CarcinomaEndometrial Carcinoma Stage III
Biogenea Pharmaceuticals Ltd. 40
Early research (Phase 1)UnknownNCT05235607
What this trial is testing

Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors

Who this might be right for
CarcinomaMelanomaBladder Cancer+1 more
Sichuan University 60
Very early researchNot Yet RecruitingNCT06156267
What this trial is testing

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

Who this might be right for
Pancreatic Cancer
Fudan University 30
Early research (Phase 1)UnknownNCT02956551
What this trial is testing

Personalized DC Vaccine for Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Sichuan University 20
Early research (Phase 1)Active Not RecruitingNCT02950766
What this trial is testing

NeoVax Plus Ipilimumab in Renal Cell Carcinoma

Who this might be right for
Kidney Cancer
Patrick Ott, MD, PhD 19
Not applicableStudy completedNCT05158621
What this trial is testing

A Screening Study Targeting Tumor-specific Antigens

Who this might be right for
Metastatic Colorectal CancerStage II/III Colon Cancer
Gritstone bio, Inc. 22
Not applicableUnknownNCT05227378
What this trial is testing

Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Shen Lin 36
Early research (Phase 1)UnknownNCT05767684
What this trial is testing

Neoantigen Derived DCs as Cancer Treatment

Who this might be right for
Refractory TumorSolid Tumor
National Health Research Institutes, Taiwan 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07365280
What this trial is testing

Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
ZSky Biotech Inc 78
Early research (Phase 1)Active Not RecruitingNCT02287428
What this trial is testing

Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

Who this might be right for
Glioblastoma
Dana-Farber Cancer Institute 56
Not applicableUnknownNCT05761717
What this trial is testing

Clinical Study of mRNA Vaccine in Patients With Liver Cancer After Operation

Who this might be right for
Posto Perative Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 67
Not applicableLooking for participantsNCT06751966
What this trial is testing

Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

Who this might be right for
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University 10
Testing effectiveness (Phase 2)Looking for participantsNCT07002203
What this trial is testing

Personalized Neoantigen Peptide Vaccines for Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRecurrent Cancer+2 more
Seqker Biosciences, Inc. 10
Load More Results